Andrea Cox is currently a Professor of Medicine, Oncology, and Immunology at The Johns Hopkins University School of Medicine in Baltimore. She earned her Ph.D. studying T cell immunology at The University of Virginia. She subsequently completed an M.D. and then Internal Medicine and Infectious Disease training at Johns Hopkins. As a member of the Viral Hepatitis Center in the Division of Infectious Diseases, she specializes in the treatment of patients with hepatitis virus infections and HIV. Her laboratory investigates human immune responses to hepatitis C virus (HCV), hepatitis B virus (HBV), dengue virus and HIV, including mechanisms through which these chronic viral infections stimulate and evade immune responses, and in HCV vaccine development.
She has been an active participant in clinical trials of direct-acting antivirals for the treatment of HCV, is a principal investigator on the first prophylactic HCV vaccine trial ever implemented in an at-risk population, and is the lead immunologist on an ACTG trial of HBV vaccines in HIV infected patients. She is dedicated to mentoring the next generation of physician scientists; directing the Johns Hopkins Medical Scientist Training Program since 2013, teaching immunology, and actively mentoring medical and graduate students, residents, and fellows. She is a member of the American Society for Clinical Investigation and Alpha Omega Alpha Honor Society.